Stay updated on Efficacy & Safety Biosimilar vs Enbrel Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety Biosimilar vs Enbrel Clinical Trial page.

Latest updates to the Efficacy & Safety Biosimilar vs Enbrel Clinical Trial page
- Check5 days agoChange DetectedThe record describes a completed Phase 3 comparison of biosimilar etanercept GP2015 with Enbrel for moderate-to-severe plaque psoriasis, including study methods, participant criteria, and efficacy and safety outcomes.SummaryDifference68%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner appears above the error page announcing NIH website transition updates and noting that NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden message.SummaryDifference0.2%

- Check40 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study record page now displays a 403 Forbidden error, blocking access to the expected study details. The screenshot shows the 403 page with the standard site footer, indicating an access restriction rather than content changes.SummaryDifference16%

Stay in the know with updates to Efficacy & Safety Biosimilar vs Enbrel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety Biosimilar vs Enbrel Clinical Trial page.